| Features: |
| Zerumbone is a sesquiterpene α,β-unsaturated carbonyl compound derived primarily from Zingiber zerumbet (shampoo ginger). It is one of the most intensively studied dietary terpenoids for anticancer activity, with a strong and internally consistent mechanism-of-action profile across multiple cancer types.
Zerumbone induces intrinsic (mitochondrial) apoptosis via: -↑ ROS generation in cancer cells -Loss of mitochondrial membrane potential -↑ Bax / ↓ Bcl-2 and Bcl-xL -Cytochrome c release -Caspase-9 → caspase-3 activation Zerumbone is a potent NF-κB inhibitor
Anti-angiogenic and anti-metastatic effects
-Observed actions include:
-↓ VEGF and HIF-1α
-↓ MMP-2 / MMP-9
-Suppression of EMT markers (N-cadherin, vimentin)
-Reduced migration and invasion
Zerumbone is a redox-bifunctional agent:
In cancer cells:
-↑ ROS beyond survival threshold
-Triggers mitochondrial collapse
In normal cells:
-Activates Nrf2
-Induces phase II detox enzymes (HO-1, NQO1, GST)
This differential redox response explains selective toxicity.
Bioavailability is limited
|
| Source: |
| Type: |
| Toxicity |
| 4889- | ZER, | Zerumbone reduces proliferation of HCT116 colon cancer cells by inhibition of TNF-alpha |
| - | in-vitro, | CRC, | HCT116 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:384 Target#:1025 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid